Pharsight

Wyeth Pharms Inc patents expiration

1. Lybrel patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6500814 WYETH PHARMS INC Hormonal contraceptive
Sep, 2018

(5 years ago)

Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 22 May, 2007

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of LYBREL before it's drug patent expiration?
More Information on Dosage

LYBREL family patents

Family Patents

2. Mylotarg patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5585089 WYETH PHARMS INC Humanized immunoglobulins
Dec, 2013

(10 years ago)

US5606040 WYETH PHARMS INC Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
Feb, 2014

(10 years ago)

US5693762 WYETH PHARMS INC Humanized immunoglobulins
Dec, 2014

(9 years ago)

US5739116 WYETH PHARMS INC Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents
Apr, 2015

(9 years ago)

US5767285 WYETH PHARMS INC Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents
Jun, 2015

(8 years ago)

US5773001 WYETH PHARMS INC Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
Jun, 2015

(8 years ago)

Drugs and Companies using GEMTUZUMAB OZOGAMICIN ingredient

Market Authorisation Date: 17 May, 2000

Treatment: Inhibiting or eliminating acute myeloid leukemia

Dosage: INJECTABLE;INJECTION

More Information on Dosage

MYLOTARG family patents

Family Patents